Attributes | Values |
---|
rdf:type
| |
Description
| - Treatment of childhood acute lymphoblastic leukemia (ALL) was unifi ed in the year 1986 in the Czech Republic using BFM protocols. Patients and methods: Children were treated in 10 and later on in 8 centers localized at the pediatric departments of the biggest hospitals. More than 1.000 children and adolescents up to the age of 18 years were treated between 1986 and 2002 on three consecutive studies ALL-BFM 83, ALL-BFM 90 and ALL-BFM 95. Results: Event-free survival and overall survival improved gradually from 58/62% on ALL-BFM 83 through 70.5/76.6% on ALL-BFM 90 until 72.1/80.2% on ALL-BFM 95. At the same time the incidence of toxic deaths was decreasing and the success in the achievement of complete remission was increasing.
- Treatment of childhood acute lymphoblastic leukemia (ALL) was unifi ed in the year 1986 in the Czech Republic using BFM protocols. Patients and methods: Children were treated in 10 and later on in 8 centers localized at the pediatric departments of the biggest hospitals. More than 1.000 children and adolescents up to the age of 18 years were treated between 1986 and 2002 on three consecutive studies ALL-BFM 83, ALL-BFM 90 and ALL-BFM 95. Results: Event-free survival and overall survival improved gradually from 58/62% on ALL-BFM 83 through 70.5/76.6% on ALL-BFM 90 until 72.1/80.2% on ALL-BFM 95. At the same time the incidence of toxic deaths was decreasing and the success in the achievement of complete remission was increasing. (en)
|
Title
| - History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic
- History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic (en)
|
skos:prefLabel
| - History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic
- History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic (en)
|
skos:notation
| - RIV/00216224:14110/11:00059282!RIV13-MSM-14110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/11:00059282
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Acute lymphoblastic leukaemia; children; treatment; diagnostics (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - memo - Magazine of European Medical Oncology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Hrstková, Hana
- Jarošová, M.
- Sedláček, P.
- Štěrba, Jaroslav
- Pospíšilová, D.
- Blažek, B.
- Gajdoš, P.
- Hak, J.
- Hrodek, O.
- Hrušák, O.
- Jabali, Y.
- Janotová, I.
- Mejstříková, E.
- Mihál, V.
- Procházková, D.
- Ptoszková, H.
- Smíšek, P.
- Starý, J.
- Timr, P.
- Toušovská, K.
- Trka, J.
- Vávra, V.
- Zdráhalová, K.
- Zemanová, Z.
- Zuna, J.
- Černá, Z.
- Šrámková, L.
|
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1007/s12254-011-0289-9
|
http://localhost/t...ganizacniJednotka
| |